Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fupin Hu

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Journal of Zhejiang University. Science. B|February 8, 2023
Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological SocietyXiaofen Liu, Chenrong Huang, Phillip J Bergen, et al.
The Journal of Infection|January 24, 2026
A nationwide genomic surveillance study of Gram-negative bacteria causing community- and hospital-acquired bloodstream infections in ChinaJingyuan Xi, Xinmiao Jia, Song Li, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilliMei Zeng, Jun Xia, Zhiyong Zong, et al.
The Lancet. Infectious Diseases|June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative studyYang Wang, Chunyan Xu, Rong Zhang, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Journal of Zhejiang University. Science. B|February 8, 2023
Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological SocietyXiaofen Liu, Chenrong Huang, Phillip J Bergen, et al.
The Journal of Infection|January 24, 2026
A nationwide genomic surveillance study of Gram-negative bacteria causing community- and hospital-acquired bloodstream infections in ChinaJingyuan Xi, Xinmiao Jia, Song Li, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilliMei Zeng, Jun Xia, Zhiyong Zong, et al.
The Lancet. Infectious Diseases|June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative studyYang Wang, Chunyan Xu, Rong Zhang, et al.
Pageof 18